JAK2 anticorps (C-Term)
Aperçu rapide pour JAK2 anticorps (C-Term) (ABIN2293126)
Antigène
Voir toutes JAK2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1103-1132, C-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- JAK2, CT (JAK2, Tyrosine-protein kinase JAK2, Janus kinase 2)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- JAK2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1103~1132 amino acids from the C-terminal region of human JAK2.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- JAK2 (Janus Kinase 2 (JAK2))
-
Autre désignation
- JAK2
-
UniProt
- O60674
-
Pathways
- Signalistation JAK/STAT, Signalisation RTK, Interferon-gamma Pathway, Positive Regulation of Peptide Hormone Secretion, Intracellular Steroid Hormone Receptor Signaling Pathway, Response to Growth Hormone Stimulus, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Platelet-derived growth Factor Receptor Signaling, Unfolded Protein Response
Antigène
-